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Abstract 
Background 
Sensation-seeking is a trait that constitutes an important vulnerability factor for a variety of 
psychopathologies with high social cost. However, little is understood either about the mechanisms 
underlying motivation for intense sensory experiences or their neuropharmacological modulation in 
humans. 
Methods 
Here, we first evaluate a novel paradigm to investigate sensation-seeking in humans. This test 
probes the extent to which participants choose either to avoid or self-administer an intense tactile 
stimulus (mild electric stimulation or MES), orthogonal to performance on a simple economic 
decision-making task. Next we investigate in a different set of participants whether this behaviour is 
sensitive to manipulation of dopamine D2 receptors using a within-subjects, placebo-controlled, 
double-blind design. 
Results 
In both samples, individuals with higher self-reported sensation-seeking chose a greater proportion 
of MES-associated stimuli, even when this involved sacrifice of monetary gain. Computational 
modelling analysis determined that people who assigned an additional positive economic value to 
MES-associated stimuli exhibited speeding of responses when choosing these stimuli. In contrast, 
those who assigned a negative value exhibited slowed responses. These findings are consistent with 
involvement of low-level approach-avoidance processes. Furthermore, the D2 antagonist haloperidol 
selectively decreased the additional economic value assigned to MES-associated stimuli in 
individuals who showed approach reactions to these stimuli under normal conditions (‘behavioural 
high sensation-seekers’). 
Conclusions 
These findings provide the first direct evidence of sensation-seeking behaviour being driven by an 
approach-avoidance-like mechanism, modulated by dopamine, in humans. They provide a 
framework for investigation of psychopathologies for which extreme sensation-seeking constitutes a 
vulnerability factor.  
Key words: sensation-seeking, impulsivity, dopamine, D2 antagonist, addiction  Accepted Manuscript
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Introduction 
Sensation-seeking is a personality trait concerned with motivation for “intense, unusual and 
unpredictable” sensory experiences (Zuckerman, 1994) which constitutes an important and well-
conceptualised individual difference (Roberti, 2004). Engagement in various sensation-seeking-type 
activities (e.g., recreational drug consumption, risky driving and sexual behaviours) covaries across 
both adults and adolescents (Carmody et al., 1985; King et al., 2012). In addition, questionnaire-
based measures of sensation-seeking personality have high heritability estimates (40-60%; 
Koopmans et al., 1995; Stoel et al., 2006) with rank order differences in scores remaining highly 
stable over time (Terracciano et al., 2011).  
Extreme sensation-seeking has been implicated in a variety of psychopathologies with high 
social cost, including substance and gambling addictions (Zuckerman, 1994; Roberti, 2004; Perry et 
al., 2011). Among individuals with substance use disorders, higher sensation-seeking score is 
associated with earlier age of onset, increased polysubstance use, more severe functional 
impairment, and poorer overall treatment outcome (Ball et al., 1994; Staiger et al., 2007; Lackner et 
al., 2013). Identification of mechanisms underlying human sensation-seeking is therefore likely to 
have high clinical relevance. 
Investigations of animal models of sensation-seeking have implicated variation in striatal 
dopamine function – particularly at ‘D2 type’ (D2/D3/D4) dopamine receptors – as playing a pivotal 
role in mediating individual preferences for novel or sensory stimulation-inducing choice options 
(Bardo et al., 1996; Blanchard et al., 2009; Shin et al., 2010). As the efficacy of striatal dopaminergic 
transmission is considered to be involved in the vigour of approach behaviours in response to salient 
stimuli (Ikemoto, 2007; Robbins and Everitt, 2007), one theoretical account proposes that the core 
basis for individual differences in sensation-seeking is in the differential activation of dopaminergic 
approach-withdrawal mechanisms in response to novel and intense stimuli (Zuckerman, 1990).  Accepted Manuscript
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Consistent with this view genetic and PET evidence has implicated differences in function at 
D2-type receptors mediating individual differences in human sensation-seeking (e.g. Hamidovic et 
al., 2009; Gjedde et al., 2010). Crucially, however, lack of behavioural paradigms analogous to those 
in the preclinical literature has meant that it has not been possible to test the approach-avoidance 
hypothesis directly in humans. Development of such an approach has previously proved highly 
fruitful with respect to other facets of impulsivity (Winstanley, 2011; Jupp and Dalley, 2014). 
Here, we first tested a novel instrumental task of human sensation-seeking-like behaviour 
that involved the opportunity to self-administer mild (but non-painful) electric stimulation (MES) 
during performance of an economic decision-making task. This task was designed to be analogous to 
a recent operant sensation-seeking paradigm developed for rodents (Olsen and Winder, 2009). We 
next used a within-subjects design to investigate the effects of the D2 dopamine receptor antagonist 
haloperidol on task performance in a different sample of healthy volunteers. We predicted that: 1) 
Individuals high in trait sensation-seeking would assign a positive economic value to the opportunity 
to experience such an ‘intense and unusual’ sensory stimulus; 2) This preference would be reflected 
in an approach-like speeded relative response time for these stimuli; and 3) Such ‘behavioural 
sensation-seeking’ would be disrupted by antagonism at D2 receptors, depending on baseline 
sensation-seeking performance (see Norbury et al., 2013). Accepted Manuscript
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Study 1 
 
Methods 
Participants 
Forty-five healthy participants (28 female), mean age 24.3 (SD 3.55), were recruited via internet 
advertisements (for further demographic information see Table 1). This sample size was chosen to 
allow us to detect a moderate-strength relationship between task performance and self-reported 
sensation-seeking trait, on the basis of previous findings that correlations between behavioural and 
questionnaire measures of other facets of impulsive behaviour are modest in strength (correlation 
coefficients up to 0.40; e.g. Helmers et al., 1995; Mitchell, 1999). An a priori power calculation 
determined that a sample size of 44 would be necessary to detect a correlation coefficient of 0.40, at 
a conventional power of 80% and alpha of 0.05). Exclusion criteria consisted of any current or past 
neurological or psychiatric illness, or head injury. All participants provided written informed consent 
and the study was approved by the University College London ethics committee. 
 
Sensation-Seeking Task 
Participants completed a novel ‘sensation-seeking task’ designed to probe the precise economic 
value (positive or negative) they assigned to the opportunity to receive an ‘intense’ sensory stimulus 
(mild electric stimulation or MES). In the first part of the task (acquisition phase) they simply learnt 
the points values associated with various different abstract visual stimuli (conditioned stimuli, or 
CSs). Eight different fractals were used as CSs, with two of them assigned to each of four possible 
points values (25, 50, 75, or 100 points). In every trial, fractals were presented as pairs, restricted to 
consist of either adjacent or equal points value stimuli, yielding ten different trial types (Fig 1).  
 Accepted Manuscript
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  The acquisition phase continued for a minimum of 80 trials until participants reached a 
criterion of choosing on 80% of trials the fractal associated with the higher points value, over the last 
ten trials where a higher points value choice was possible. After this learning stage was completed, 
participants progressed to the second part of the task (test phase).  
  In the test phase, half the choice stimuli became additionally associated with the chance of 
receiving non-painful, mild MES to the hand. These fractals will henceforth be referred to as CS+ (for 
full details see Fig 1). The other fractals were not associated with electrical stimulation and so are 
referred to as CS-. For each points value, one of the associated fractals became CS+ (chance of MES), 
while the other was CS- (no chance of MES). This yielded three types of trial: those where CS+ was 
the lower points option, those where CS+ was the higher points option, and, crucially, those where 
the CS+ and CS- stimuli were of equal points value.  
  Participants thus continued to make choices between fractal pairs, with the only difference 
being that now half of the choice options were associated with the chance of receiving the MES –  
including, importantly, on trials where both fractals were of the same points value. The key 
experimental question was whether some participants’ choices would be biased towards selecting 
the CS+ stimuli, when it was of equal points value to, or even less than, the CS-. The degree of bias in 
participants’ choice towards or away from CS+ stimuli, with respect to the relative points value of 
the CS+ option, thus allowed precise calculation of the economic value (positive or negative) each 
participant assigned to the opportunity to receive the additional intense sensory stimulus (see 
Computational modelling analysis). 
  Participants completed 100 test phase trials (ten per trial type), and were told they would be 
paid a cash bonus at the end which depended on the total number of points accrued. To increase the 
salience of the tactile stimulus, receipt of MES was probabilistic, in both occurrence and timing. The 
probability of receiving the MES given selection of a CS+ stimulus was 0.75, with the onset of MES 
occurring randomly during a 2500ms inter-stimulus interval (ISI).  Accepted Manuscript
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Prior to initiation of the task, participants rated their preference for each of the fractals to 
be used in the paradigm on a computerised VAS (ranging ‘like’ – ‘dislike’). This measure was 
repeated for a second time following completion of the acquisition phase (i.e. after learning the 
points value associated with each CS), and for a third time at the end of the experiment (i.e. 
following introduction of the MESs). For details of apparatus and stimulation parameters used to 
deliver the MES see Supplementary Information. 
 
Design 
Following consent and standardised task instructions, the amplitude of the electrical stimulation was 
calibrated individually for each participant via a standardised work-up procedure. Specifically, 
participants received a series of single stimulation pulses, starting at a very low amplitude (0.5mA; 
generally reported by participants as being only just detectable) and gradually increasing in current 
strength until the stimulation was rated as 6 out of 10 on a visual analogue scale (VAS) ranging from 
0 (‘just detectable’) to 10 (‘painful or unpleasant’) – a level at which participants endorsed a 
description of the sensation as being “stimulating but not painful”. This procedure was repeated 
twice for each participant to ensure consistency.  
Participants also completed several self-report measures: a revised measure of the 
Sensation-Seeking Scale version V (the SSS-V-R; Zuckerman, 1994; Gray and Wilson, 2007); a 
measure of hedonic tone, the Snaith-Hamilton Anhedonia Scale (Snaith et al., 1995); and the trait 
scale of the State-Trait Anxiety Inventory (Spielberger et al., 1970). The latter two measures were 
included in order to test the possibility that individual differences in MES preference may be related 
to trait anxiety or current state (an)hedonia rather than being driven by sensation-seeking 
personality per se. Demographic information regarding years of education, cigarette and alcohol 
consumption, recreational drug use, and frequency of engagement in gambling-related activities was 
also collected. 
 Accepted Manuscript
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Computational modelling analysis 
For test phase data, it was assumed that a choice between two CSs, A and B (where A is the CS+ 
stimuli and B is the CS-), could be represented as: 
  VA = RA + θ 
  VB = RB 
where  
  RX is the points value of stimulus X 
  θ is the additional value (in points) assigned to the opportunity to receive the MES (positive 
or negative) 
  VX represents the overall value of each option.  
 
This model was then fit across all test phase choice data from each participant via a sigmoidal choice 
(softmax) function: 
 
P(choose A) = 1 / (1 + exp(-β*(VA-VB)))   
     
Values of the free parameters θ and β (the softmax temperature parameter, a measure of choice 
stochasticity) were fit to the data on a subject-by-subject basis using log likelihood maximisation.  
 
 
Results 
Individual differences in preference for additional intense sensory stimulation 
Overall, participants chose the MES-associated stimulus (CS+) on 20.4% (SD 17.6) of the trials where 
these represented the lower points option, 68.9% (24.8) of the trials where they were the higher 
points option, and 45.2% (19.9) of trials where CS+ and CS- stimuli were equal in points value. There Accepted Manuscript
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was a significant effect of trial type on proportionate choice of CS+ stimuli (F2,88=157.29, p<0.001). 
Post-hoc t-tests revealed that overall participants chose the CS+ option significantly less frequently 
on lower points trials than equal points trials, and significantly more often on higher points trials 
than equal points trials (t44=-11.997, p<0.001; t44=-8.102, p<0.001, respectively). 
Importantly, there was substantial variation in preference for the MES-associated option on 
trials where CS+ and CS- options were equal in points value. Mean proportionate choice of CS+ 
stimuli ranged from 7.5% to 92.5% (relative CS+ value of 0, Fig 2A). An estimate of significantly 
biased choice on these trials can be made by sampling the binomial distribution – for 40 trials and an 
alpha of 0.05 this threshold is approximately 26/40 (0.65) for significantly high choice and 13/40 
(0.35) for significantly low choice. Based on these thresholds, 8/45 (or 18%) of participants chose a 
significantly high proportion of CS+ stimuli – in other words, significantly sought the MES – and 
13/45 (29%) of participants significantly avoided the CS+ options.  
Consistently high choice of MES-associated stimuli was observed in a subset of participants – 
even on trial types where the CS+ was the lower points value option, i.e. involved sacrifice of 
economic value (relative CS+ value of -25, Fig 2A). 
In order to test whether participants’ choice of the MES-associated stimuli varied 
significantly over the course of the task (i.e. whether preference changed with decreasing stimulus 
novelty), test phase trials were binned into four sections. A repeated-measures ANOVA with the 
within-subjects factor of time (four levels) found no evidence for a main effect of time-on-task on 
proportionate choice of CS+ stimuli across all subjects (p>0.1). Overall choice of CS+ stimuli was also 
unrelated to number of trials taken to reach criterion performance, or proportion of correct 
responses (higher points value choice on trials where this was possible) during the acquisition phase 
(p>0.1), suggesting that preference for MES-associated stimuli was not associated with the learning 
of the points values during the first part of the task. MES preference was also not related to current 
amplitude (p>0.1). Accepted Manuscript
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The computational modelling analysis describing the value (in points) that participants 
assigned to opportunity to receive the MES (θ) provided a good account of task performance (for 
details see Supplementary Information). Figure 2B shows individual psychometric curves for 
probability of choosing the MES-associated option (CS+) as a function of its relative points 
(monetary) value, generated by fitting the model to choice data across all trial types for each 
participant.  
 
Relationship between economic value assigned to opportunity to receive intense sensory 
stimulation and reaction time for MES vs non MES-associated stimuli.  
Individual θ values were strongly negatively correlated with difference in choice reaction time (RT) 
for CS+ vs CS- stimuli (r=-0.690, p<0.001; Fig 2B). Specifically, participants who chose a greater 
proportion of MES-associated stimuli were faster to choose these stimuli (suggestive of conditioned 
approach). In contrast, participants who tended to avoid CS+ stimuli were slower to choose them 
(suggestive of conditioned suppression) (see Pearce, 1997). This was not a time-on-task effect (e.g. 
due to a tendency to decrease both mean reaction time and choice of the CS+ over the course of the 
task) as this relationship remained strongly significant when considering trials from only the latter 
half of the test phase (first half of trials r=-0.692, second half of trials r=-0.625, both p<0.001).   
 
Relationship between task performance and self-report measures.  
Individual θ values were significantly positively related to self-reported sensation-seeking score, such 
that participants who reported higher trait sensation-seeking assigned a greater value to 
opportunity to receive the mild electric stimulation (r=0.325, p=0.043; Fig 3A).  
Theta value was unrelated to trait anxiety, self-reported hedonic tone, current amplitude, or 
years of education (all p>0.1). Non-parametric tests were used to relate task performance to self-
reported alcohol and tobacco use, as these data were substantially positively skewed. Independent-Accepted Manuscript
 
          11 
samples median tests revealed that individuals who assigned a positive value to the opportunity to 
receive the MES (i.e. θ>0, N=17) smoked significantly more cigarettes per week (Fisher’s p=0.006) 
and showed a nonsignificant trend towards consuming more alcoholic drinks per week (p=0.098) 
than individuals who tended to avoid the MES (i.e. θ<0, N=28) (mean cigarettes per week 6.7±10.4 
vs 2.5±9.9; mean drinks per week 4.2±3.9 vs 3.4±4.9). There was no significant difference in mean θ 
value between individuals who did vs didn’t (N=15 vs N=30, Table 1) report any recreational 
substance use other than alcohol or tobacco over the past 12 months (independent samples t-test, 
p>0.1). There was no difference in mean θ value between male and female participants 
(independent samples t-test, p>0.1). 
MES value (θ) was also significantly positively related to mean change in VAS ‘liking’ rating 
for CS+ stimuli following introduction of the mild electric stimuli (i.e. between rating sessions 2 and 
3; r=0.368, p=0.013; Fig 3B). Participants who assigned positive MES values tended to increase their 
liking rating of MES-associated stimuli, whilst participants with negative values tended to decrease 
their ratings. 
Values of the model parameter indexing choice stochasticity (β; a measure of the extent to 
which participants’ choice was influenced by the difference in value between the two options) were 
unrelated to both self-reported SS trait and θ values (p>0.1) – suggesting that higher sensation-
seeking or MES-seeking individuals were not any less value-driven in their choice behaviour than 
their lower sensation-seeking counterparts.  
 Accepted Manuscript
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Study 2  
 
Methods 
Participants  
Participants were 30 healthy males, mean age 22.3 (SD 2.74; Table 1). Potential effects of 
haloperidol in female volunteers who might be pregnant precluded use of the drug in women in this 
study. Sample size (N=30) was based on the strength of the MES value/RT effect relationship we 
observed in Study 1. It was calculated that a sample of 29 participants should allow us to replicate 
(and detect any effects of haloperidol on) a true effect size of r=0.50, at a power of 80% and an alpha 
of 0.05. Exclusion criteria consisted of any current major illness, current or historic incident of 
psychiatric illness, and/or history of head injury. All subjects gave informed written consent and the 
study was approved by the University College London ethics committee. 
 
Design  
The study was carried out according to a within-subjects, double-blind, placebo-controlled design. 
On the first session, participants gave informed consent and completed the sensation-seeking task, 
in order to reduce the impact of any practice effects on performance across the subsequent two 
sessions (under placebo or drug). They then completed the UPPS impulsivity questionnaire 
(Whiteside and Lynam, 2001) which has subscales of sensation-seeking and three other factor 
analysis-derived impulsivity facets. This measure was chosen in order to evaluate the selectivity of 
the relationship between task performance and sensation-seeking, as compared to other kinds of 
impulsivity. The sensation-seeking subscale of the UPPS is predominantly derived from items of the 
SSS-V, and therefore scores on the two measures intercorrelate highly (ibid). A standardised non-
verbal measure of mental ability was also administered (Raven’s 12-item Advanced Progressive 
Matrices; Pearson Education, 2010).  Accepted Manuscript
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On the second and third sessions, participants arrived in the morning and were administered 
either 2.5mg haloperidol or a placebo (drug and placebo were indistinguishable). A dose of 2.5mg 
haloperidol was chosen, in order to be greater than that given in a previous study where 
inconsistent drug effects were observed (2mg; Frank and O’Reilly, 2006), but less than that used in 
other behavioural studies where significant negative effects of haloperidol on mood or affect were 
detected (3mg; Zack and Poulos, 2007; Liem-Moolenaar et al., 2010). Testing commenced 2.5 hours 
after ingestion of the tablet, in order to allow drug plasma levels to reach maximum concentration 
(Midha et al., 1989; Nordström et al., 1992).   
Following this uptake period, participants completed VAS measures of mood, affect, 
potential physical side effects and knowledge of the drug/placebo manipulation, and performed the 
sensation-seeking task described in Study 1. The Addiction Research Centre Inventory of 
psychoactive drug effects (ARCI; Martin et al., 1971) was also administered, as this previously has 
been shown to be sensitive to haloperidol (Ramaekers et al., 1999). Participants further completed 
one of two equivalent forms of the letter-digit substitution test (LDST; van der Elst et al., 2006) – a 
simple pencil-and-paper test of general psychomotor and cognitive performance. Arterial heart rate 
and blood pressure were monitored pre and post-drug administration.  
The sensation-seeking task was as described for Study 1. For this study, participants 
completed an additional set of VAS ratings at the end of the task to test learning of CS+/CS- (MES-
associated vs non MES-associated) contingencies. For each CS, participants rated how strongly they 
believed choosing that stimulus had been associated or not with the chance of receiving electrical 
stimulation (‘no chance of shock’ – ‘chance of shock’). The individualised work-up procedure was 
repeated on every session, to ensure that subjective intensity (as opposed to actual current 
amplitude) was matched across sessions. Drug/placebo order was counterbalanced across subjects, 
with a minimum of a one-week washout period between the two test sessions (the mean time 
between visits was 18 days). 
 Accepted Manuscript
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Analysis 
Computational modelling analysis of the sensation-seeking task was as described for Study 1. A 
repeated-measures ANOVA with the within-subjects factor of drug (haloperidol vs placebo), and the 
between-subjects factor of drug order (first vs second test session) was used to analyse key 
dependent variables from test session data. Specifically, these were participant-determined current 
amplitude, modelling parameters describing MES value (θ) and choice stochasticity (β), mean choice 
reaction time, and individual reaction time effect (median RTCS+ – median RTCS-). All reported simple 
effects analyses are via pairwise comparison, with the Bonferroni adjustment for multiple 
comparisons.  
Measures of general and subjective drug effects (VAS, ARCI, LDST scores and cardiovascular 
measures) were compared between test sessions via paired-sample t-tests. One participant was 
unable to attend for a final test session and so his data were excluded from the analysis. A further 
participant failed to reach criterion level performance in the acquisition stage of the task on both 
test sessions, and so his data were also excluded, yielding a final N of 28. 
All statistical analyses were carried out in SPSS 19.0 (IBM Corp., Armonk, NY), except the 
computational modelling analysis which was implemented in Matlab R2011b (Mathworks, Inc., 
Sherborn, MA). 
 
Results 
Baseline-dependent effects of haloperidol on behavioural sensation-seeking  
 The main findings of Study 1 were replicated in the baseline session data from our second sample of 
participants (significant relationships in the expected directions between θ values and both 
individual RT effect and self-reported sensation-seeking; Fig S1). A concordance analysis between 
data from baseline and placebo sessions also indicated fair-to-good reliability of estimates of θ value Accepted Manuscript
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across sessions (see Supplementary Information) – supporting the validity of our use of a repeated-
measures design. 
When considering data from the two test (drug/placebo) sessions, overall, participants again 
chose the shock-associated stimulus (CS+) significantly more often on higher points than equal 
points trials, and on equal compared with lower points trials, on both placebo and drug sessions 
(main effect of trial type; F2,54=138.54, ƞp
2=0.837, p<0.001; difference between types all p<0.001; 
mean (± SD) choice on placebo was 0.806 ± 0.19, 0.398 ± 0.17, 0.126 ± 0.13 respectively for these 
trial types; while on haloperidol 0.744 ± 0.19, 0.399 ± 0.15, 0.158 ± 0.15). 
There were no significant overall effects of haloperidol treatment on current amplitude, 
points value assigned to the MES (θ), choice stochasticity (β), mean reaction time or relative reaction 
time for MES vs non MES-associated stimuli (all p>0.1). Drug order (active preparation on first vs 
second test session) was not a significant between-subjects factor for any of the dependent variables 
(p>0.1), and there was no overall drug*drug order interaction (p>0.1). Therefore drug order was 
discarded from the model for subsequent analyses, in order to maximise sensitivity. 
The strong relationship between the points value participants assigned to receipt of the MES 
and relative choice reaction time for MES-associated vs non MES-associated stimuli observed in 
Study 1 was replicated in the second sample under placebo conditions (r=-0.602, p=0.001), but, 
intriguingly, not under haloperidol (r=-0.199, p>0.1; Fig 4A).  
A post-hoc analysis revealed that there was indeed a significant attenuation of this 
relationship under haloperidol (Fisher r-to-Z transformed Pearson-Filon test for decrease in 
correlation coefficient; Z=-1.735, p=0.041, one-tailed; Raghunathan et al., 1996). Thus, haloperidol 
treatment appeared to abolish the approach-avoidance effect, with respect to relative preference 
for the intense sensory stimulus. Similarly, although self-reported sensation-seeking score was 
significantly, and selectively, positively correlated with MES value (θ) on placebo (r=0.391, p=0.040; 
all other UPPS impulsivity subscale scores unrelated to MES preference, p>0.1), this was not the case Accepted Manuscript
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under haloperidol (r=-0.127, p>0.1; Steiger’s Z for significant difference in correlation coefficient 
between drug conditions=2.25, p=0.024; Steiger, 1980).  
Based on the above finding, in conjunction with our previous observation that the effects of 
a D2ergic drug may depend on baseline sensation-seeking (Norbury et al., 2013), a further analysis 
was conducted in order to check for baseline-dependent drug effects that may have been masked in 
the group-level analysis. In order to discover what was driving the attenuation of the RT effect under 
drug, participants were grouped according to whether they showed conditioned approach (speeded 
reaction time to CS+ vs CS- stimuli, i.e. individual RT effect <0, N=8) or conditioned suppression 
(slowed RT to CS+ vs CS- stimuli, i.e. individual RT effect >0, N=20) of their responses towards the 
intense sensory stimulation under placebo conditions.  
When this ‘approach’ or ‘avoid’ grouping was added to the model as a between-subjects 
factor, there was a significant interaction between drug treatment and group on value assigned to 
the MES (significant drug*group interaction on θ value; F1,26=10.64, ƞp
2=0.290, p=0.003; interaction 
with β p>0.1). Simple effects analysis revealed a significant decrease in MES value in the approach 
group on haloperidol vs placebo (F1,26=7.97, ƞp
2 =0.235, p=0.009). By contrast, there was no effect of 
drug on MES value in the avoidance group (p>0.1; Fig 4B). Thus, haloperidol appeared to selectively 
attenuate MES value in individuals who exhibited approach behaviour towards the intense sensory 
stimulus under baseline conditions. 
Approach and avoid groups did not differ in age, weight, estimated IQ or self-determined 
current intensity (independent samples t-tests, all p>0.1), but did differ in UPPS sensation-seeking 
score (t26=2.261, p=0.032, significantly higher mean score in the ‘approach’ group; 40.9±8.1 vs 
32.9±8.5). Similarly to Study 1, independent-samples median tests revealed that individuals in the 
approach group smoked significantly more cigarettes per week than the avoid group (Fisher’s 
p=0.022), and showed a non-significant trend towards greater weekly alcohol consumption 
(p=0.096; mean cigarettes per week 20±25 vs 3.9±13; mean drinks per week 12±13 vs 3.5±3.9). Accepted Manuscript
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 The effect of haloperidol on θ value (difference in value between drug and placebo sessions) 
was unrelated to age, weight, estimated IQ, drug effect on overall mood or alertness visual analogue 
scale VAS ratings, drug effect on the ‘sedation’ or ‘dysphoria’ scales of the Addiction Research Centre 
Inventory (ARCI), or drug effect on general psychomotor function (LDST score; all p>0.1).  There was 
also no significant relationship between effect of drug on θ value and number of alcoholic drinks 
consumed or cigarettes smoked in an average week (Spearman’s ρ<0.25, p>0.1). Subjects who 
had/hadn’t (N=10 vs N=18, Table 1) engaged in any recreational drug use other than alcohol or 
tobacco over the last 12 months did not differ in the effect of haloperidol on θ value (independent 
samples t-test, p>0.1).  
 
Subjective and general psychomotor drug effects 
The above findings could not be explained by generic effects of drug treatment. Overall, there were 
no significant effects of haloperidol on VAS ratings of mood, affect, or potential physical side effects 
(16 scales, all p>0.1; for details see Table S1). There was also no effect of haloperidol on any ARCI 
subscale score (MBG ‘euphoria’, PCAG ‘sedation’, LSD ‘dysphoric and psychotomimetic effects’, BG 
and A ‘stimulant-like effects’ scales all p>0.1), or cardiovascular measures (blood pressure and heart 
rate, p>0.1). There was no effect of drug treatment upon participant ratings of whether they 
believed they were on the drug or placebo session (p>0.1). Finally, there was no effect of haloperidol 
on general psychomotor function as indexed by LDST performance (p>0.1). 
 
Effects of drug on learning 
Finally, we examined the hypothesis that the observed effects of haloperidol could be due to 
differences in learning between drug and placebo sessions. We found no effect of haloperidol on 
number of trials required to reach criterion performance in the first phase of the task (p>0.1). 
Participants’ mean ‘shock knowledge’ ratings for CS+ and CS- stimuli (ratings on a VAS ranging from Accepted Manuscript
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‘chance of shock’ (+300) to ‘no chance of shock’ (-300)) were entered into a repeated-measures 
model with the within-subjects factors of drug (haloperidol vs placebo) and CS type (CS+ vs CS-), 
revealing a significant main effect of CS type (F1,27=74.56, ƞp
2=0.734, p<0.001; mean (± SEM) rating of 
CS+ stimuli 146 ± 18.2, mean rating of CS- stimuli -150 ± 19.1), but no effect of drug treatment 
(p>0.1) or drug*CS type interaction (p>0.1) on explicit knowledge of MES associations. When 
approach’ vs ‘avoid’ group was added to the model as a between-subjects factor, there was no 
difference between groups in the effect of drug on shock knowledge ratings (drug*group, p>0.1), or 
the effect of drug depending on CS type (drug*CS type*group, p=0.09).Accepted Manuscript
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Discussion  
We examined how the opportunity to experience an intense sensory stimulus (mild electric 
stimulation, MES) influenced behaviour during a simple economic decision-making task, and, 
subsequently, how this behavioural index of sensation-seeking was affected by the D2 dopamine 
receptor antagonist haloperidol. Above chance choice of stimuli associated with intense tactile 
stimulation occurred reliably in some participants, even when this choice involved the sacrifice of 
monetary gain. This finding is consistent with the intense sensory stimulation being considered to be 
appetitive in these individuals. In support of this interpretation, participants who chose a greater 
proportion of MES-associated stimuli had higher self-reported sensation-seeking scores, increased 
their ‘liking’ ratings of these stimuli following the introduction of the MESs, and assigned a positive 
economic value to the opportunity to receive the additional sensory stimulation in a well-fitting 
computational model of task performance.  
Importantly, there was a highly significant relationship between preference for the intense 
sensory stimulus and choice reaction times – consistent with the notion that the MES had 
motivational significance to participants. In both samples, participants who chose a greater 
proportion of MES-associated stimuli showed a relative speeding of their responses when choosing 
these stimuli, with the opposite effect observed in people who tended to avoid them. In conjunction 
with previous observations that individuals generally show speeded response times for appetitive 
stimuli, but are slower to approach aversive stimuli (Crockett et al., 2009; Wright et al., 2012), this 
suggests that the opportunity for intense sensory stimulation influenced participants’ choice via an 
approach–avoidance-like mechanism.  
Critically, this effect was not evident under the influence of a D2 receptor antagonist. This 
was due to a selective decrease in the economic value assigned to receipt of the intense sensory 
stimulus in participants who exhibited speeded relative reaction times towards (or displayed 
approach reactions to) the MES under placebo conditions (behavioural ‘high sensation-seekers’). Accepted Manuscript
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The results presented here are in line with broader background of evidence from both 
humans and animals that relates trait sensation-seeking to variation in dopaminergic 
neurotransmission, particularly in striatal regions (Hamidovic et al., 2009; Olsen and Winder, 2009; 
Shin et al., 2010; Gjedde et al., 2010; Norbury et al., 2013). A combination of evidence from genetic 
and PET radioligand displacement studies suggests that individuals higher in sensation-seeking 
personality may have both higher endogenous dopamine levels and greater dopaminergic responses 
to cues of upcoming reward in the striatum (Riccardi et al., 2006; Gjedde et al., 2010; O’Sullivan et 
al., 2011). According to one influential model of the role of dopamine in striatal function (Frank, 
2005), in the normal state this may contribute to increased inhibition of ‘NoGo’ (action inhibition) 
pathway neurons via increased stimulation of inhibitory post-synaptic D2 receptors. This in turn 
would result in greater overall thalamic disinhibition or ‘Go’ bias (favouring action expression) in 
high sensation-seekers – particularly in the presence of reward cues.  
Haloperidol is a ‘silent’ D2 receptor antagonist (blocks endogenous dopamine signalling via 
D2 receptors; Cosi et al., 2006), and D2 antagonists have previously been shown to preferentially 
affect striatal function (Kuroki et al., 1999; Honey et al., 2003). Therefore, it is possible that under 
haloperidol the responses of higher sensation-seekers may be ‘normalised’ (increase in resemblance 
to lower sensation-seekers) by allowing increased ‘NoGo’ pathway output. This would explain our 
finding of a selective decrease in appetitive reactions to the intense sensory stimulation in the higher 
sensation-seeking (‘approach’ group) individuals.  
Our finding of a significant effect of haloperidol on choice, in the absence of any influence on 
learning, is consistent with recent work suggesting that that D2 antagonists may have strong effects 
on choice of rewarding-predicting stimuli whilst leaving learning intact (Eisenegger et al., 2014). 
However, it is important to note that the putative mechanism suggested above assumes a 
predominantly post-synaptic effect of haloperidol (see Frank and O’Reilly, 2006). Despite our 
attempt to ensure significant post-synaptic receptor binding by use of a greater dose than the 
previously cited study (where mixed pre- and post-synaptic D2ergic effects were thought to be Accepted Manuscript
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observed), we can provide no direct evidence of this.  Further, inferences regarding the brain regions 
involved in our findings are speculative and would need to be tested in further work, for example 
involving functional imaging.  
The studies presented here have some limitations. Firstly, as sensation-seeking behaviours in 
the real world can take many different forms, it might appear surprising that use of a single, tactile 
sensory stimulus (mild electric stimulation) is able to sufficiently capture sensation-seeking 
behaviour in all individuals. However, our findings are consistent with a previous study reporting 
distinct physiological response profiles to mild electric shock in low and high self-reported sensation-
seekers (De Pascalis et al., 2007). We would not seek to claim that performance on our task captures 
all of sensation-seeking personality, as this is a complex multidimensional trait, but it may tap 
operational sensation-seeking-like behaviour in at least a subset of high sensation-seeking 
individuals – thereby allowing us to probe underlying neural mechanisms in the laboratory (e.g. with 
pharmacological manipulations). In analogous fashion, there is some evidence that apparently 
dissimilar animal operationalisations of ‘sensation-seeking’ behaviour may tap at least partially 
overlapping neural circuitry (e.g. Parkitna et al., 2013). 
Crucially, in both our studies choice of MES-associated stimuli was found to correlate 
selectively with total self-reported sensation-seeking scores, which probe multiple classes of 
sensation-seeking–type behaviours. Although these relationships were of only moderate strength, it 
should be noted that these findings are at the higher end of the range of those generally found 
between behavioural and questionnaire measures of impulsive behaviour (Helmers et al., 1995; 
Mitchell, 1999). We also found some evidence of greater recreational substance consumption 
amongst individuals who assigned a positive value towards opportunity to experience the MES, 
indicating that task performance may relate to real-life engagement in sensation-seeking 
behaviours.  
Secondly, as our drug finding is based on a significant decrease in value in one (previously 
higher mean value) subgroup, an alternative explanation of our findings from Study 2 is that this Accepted Manuscript
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simply represents a regression to the mean effect. However, against this interpretation, we found 
evidence of fair-to-good reliability of θ values generated from the same participants across multiple 
sessions of our novel paradigm (Supplementary Information).  
Furthermore, the sub-grouping for Study 2 is based on individual difference in relative 
choice RTs rather than θ values per se (although the two are significantly correlated). We also used 
our estimate of RT effect from the second or third testing session (placebo session) to group 
participants – a strategy which has previously been argued to help guard against regression to the 
mean effects (Barnett et al., 2005). Taken together, we would contend that these factors argue 
against a purely trivial effect of haloperidol on MES value in the approach or ‘high sensation-seeking’ 
individuals. 
Thirdly, although haloperidol is considered to be a selective D2 receptor antagonist (it binds 
over 15 times more strongly to D2 than D1 receptors in rat and human cloned cells; Arnt and 
Skarsfeldt, 1998), it has also been shown to have modest affinity for the α-1 adrenoreceptor and the 
serotonin 2A receptor in post-mortem human brains (Richelson and Souder, 2000). Therefore we 
cannot be completely certain about the mechanism underlying our drug effects. As haloperidol has 
previously been reported to induce high levels of brain D2 receptor occupancy at relatively low oral 
doses (60–70% at 3 mg and 53%–74% at 2mg, Nordström et al., 1992; Kapur et al., 1997), we are 
confident that dose used in our study (2.5mg) was sufficient to antagonize central D2 receptors in 
our participants. Another potential limitation is the possibility that the behavioural effects we 
observed are due to some general effect of haloperidol treatment, e.g. increased negative affect in 
some participants. However against this interpretation the effect of drug on MES value was 
unrelated to differences in mood, affect, sedation or dysphoria ratings, or our measure of general 
psychomotor function, between drug and placebo sessions.  
In summary, the novel paradigm introduced here appears to tap a dimension of willingness 
to self-administer ‘intense and unusual’ sensory stimulation, together with associated behavioural 
invigoration. For participants who choose to approach rather than avoid this kind of stimulation, we Accepted Manuscript
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propose that it is intrinsically rewarding; and that, similar to analogous findings from the animal 
literature, this appetitive response involves the D2 receptor dopamine system. These findings may 
aid investigation of various psychopathologies for which more extreme sensation-seeking scores 
constitute a vulnerability factor.  
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  Study 1  Study 2 
N (female)  45 (28)  28 (0) 
Age (years)  24.3 (3.55)  22.3 (2.74) 
Years of education  16.1 (3.1)  -   
Raven’s 12-APM score  -    9.1 (2.5) 
SSS-V-R total score 
(range) 
261 (46) 
(162-352) 
-   
UPPS SS score 
(range) 
-    23.2 (5.8) 
(18-47) 
Alcohol (drinks per week)  3.7 (4.5)  5.9 (8.7) 
Tobacco (cigarettes per week)  4.1 (10.2)  8.4 (18.3) 
Other drug use (N):     
        None  30  18 
        Marijuana (ever)  8  5 
        Marijuana (regularly)  5  1 
        Stimulant use (ever)  2  4 
Gambling behaviour (N):     
        Never  39  17 
        Several times per year  5  3 
        Several times per month  1  7 
        Weekly or more  0  1 
SS=sensation-seeking; Raven’s 12-APM=Raven’s Advanced Progressive Matrices non-verbal IQ test 
(12-item version); SSS-V-R=Sensation-Seeking Scale version V (Revised); UPPS SS=UPPS impulsivity 
scale sensation-seeking subscale score. Other demographic scores refer to behaviour over the last 
12 months. Unless otherwise specified, figures represent mean (SD) for each group.  
Table 1. Demographic information for participants Accepted Manuscript
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Figure 1. ‘Sensation-seeking’ task.  
In the first part of the task (acquisition phase), participants were presented with a series of forced 
choice decisions between pairs of abstract fractal images. There were eight different fractal stimuli 
(conditioned stimuli, or CSs), with two different CSs assigned to each of four possible points values 
(25, 50, 75, or 100 points; with which choice option a particular fractal represented randomised for 
every participant). Choice pairs were restricted to consist of either adjacent or equal points value 
stimuli, yielding ten trial types. The acquisition phase of the task continued for a minimum of 80 
trials until participants reached a criterion level of performance – namely 80% or above higher points 
value choices over the last ten trials where a higher points value choice was possible. After this 
learning stage was completed, participants progressed to the second part of the task (test phase).  
 
For the test phase, participants were instructed that all stimuli were associated with the same points 
value as before, but that some of the stimuli were now associated with the chance of receiving a 
mild electric stimulus (MES) to their non-dominant hand (the magnitude of the MES was individually 
calibrated to be “stimulating but not painful” prior to starting the task). Specifically, half of the 
stimuli became designated as CS+s (chance of MES), and the other half CS-s (no chance of MES), in 
such a way that trials fell into one of three types: those where the CS+ was the lower points option, 
those where the CS+ was the higher points option, and, crucially, those where the CS+ and CS- 
stimuli were of equal points value. In order to increase the salience of the tactile stimulus, receipt of 
the electrical stimulation was probabilistic in both occurrence and timing. The probability of 
receiving the MES given selection of a CS+ stimulus was 0.75, with the onset of the MES occurring 
randomly during a 2500ms inter-stimulus interval (ISI), throughout which participants were 
presented with a blank screen.  
 Accepted Manuscript
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Figure 2. Interindividual variation in task performance. 
 
A Individual psychometric functions for probability of choosing the CS+ (mild electric stimulation or 
MES-associated) option as a function of its relative points (monetary) value, generated for each 
participant from choice data across all trial types (black circles indicate actual proportionate choice 
for each trial type). The left/right translation of each function represents the influence of MES value 
(or θ) on choice, with the gradient of the function determined by the softmax temperature 
parameter β (a measure of the stochasticity of participants’ choice). A leftward shift in the function 
reflects a positive effect of opportunity for intense tactile stimulation on choice – i.e. greater choice 
of the MES-associated options than would be expected from points-based choice alone. 
B The value an individual assigned to the opportunity to receive the MES (θ) strongly predicted their 
difference in choice reaction times to CS+ vs CS- stimuli (median RTCS+ – median RTCS-; r =-0.690, 
p<0.001). The opportunity for extra sensory stimulation slowed choice of these options in 
participants for whom it was aversive (low proportionate choice of the CS+; bottom right quadrant), 
but speeded choice in participants for whom it was appetitive (high choice of the CS+; top left 
quadrant, orange shading). Black dashed lines indicate 95% confidence intervals. N=45Accepted Manuscript
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Figure 3. Relationship between task performance and self-report measures. 
A Total self-reported sensation-seeking score was significantly positively related to the value 
participants assigned to opportunity to receive mild electric stimulation or MES (r=0.325, p<0.05).  
B There was a positive relationship between value assigned to receipt of the intense sensory 
stimulation (θ) and mean change in VAS ‘liking’ rating of MES-associated (CS+) stimuli following the 
introduction of the additional electrical stimulation (r=0.368, p<0.05). Dashed lines indicate 95% 
confidence intervals. N=45 
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Figure 4. Effects of haloperidol on the value assigned to intense sensory stimulation. 
A In a second sample of healthy volunteers, the value assigned to intense sensory stimulation (mild 
electric stimulation or MES) was significantly related to relative choice reaction time for MES vs non 
MES-associated stimuli on placebo (r=-0.602, p=0.001), but not under haloperidol (p>0.1; significant 
decrease in regression coefficient, p<0.05). Dashed lines indicate 95% confidence intervals. 
B If subjects were divided into those who approached (showed speeded relative reaction times 
towards, N=8) and those who avoided (showed slowed relative reaction times towards, N=20) the 
opportunity for the intense sensory stimulation under placebo, there was found to be a significant 
interaction between sensation-seeking group and effect of drug (p<0.01). Haloperidol decreased the 
economic value assigned to the MES only in those participants who exhibited approach reactions 
towards MES-associated stimuli under normal conditions (‘high sensation-seekers’ or HSS; cf ‘low 
sensation-seekers’ or LSS). Error bars represent SEM. **p=0.01, ns p>0.10, drug vs placebo. N=28 Accepted Manuscript
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